Thyroid function and hypothyroidism: why current diagnosis and treatment fall short for many, and how new approaches are transforming care | Antonio Bianco, M.D., Ph.D.

Peter Attia

Nov 17, 2025

Episode description

View the Show Notes Page for This Episode

Become a Member to Receive Exclusive Content

Antonio Bianco is a world-renowned physician-scientist and expert in thyroid physiology and metabolism. In this episode, Antonio explores the complex biology of thyroid hormone production, conversion, and regulation—highlighting how deiodinase enzymes modulate hormone activity at the tissue level and why that matters for interpreting lab results. He discusses the shortcomings of relying solely on TSH as a marker of thyroid function, the ongoing debate around combination therapy with T3 and T4 versus standard T4 treatment, and how genetics, tissue sensitivity, and individual variability influence thyroid hormone metabolism. The conversation also examines how hypothyroidism affects energy, mood, cognition, and longevity; why some patients remain symptomatic despite "normal" labs; and how future research could reshape treatment paradigms.

We discuss:

How the thyroid produces, stores, and activates hormones like T4 and T3 to finely regulate thyroid activity [2:45];
How fasting alters thyroid hormones to conserve energy [12:45];
Action of the deiodinases: how D1, D2, and D3 enzymes control the activation and inactivation of thyroid hormones [19:15];
The normal function of thyroid hormone and the roles of the hypothalamus, pituitary gland, and deiodinases in maintaining hormonal balance [23:30];
Why understanding thyroid physiology is essential for proper diagnosis and treatment of hypothyroidism [33:45];
Testing for thyroid hormones: understanding free vs. total levels, the limitations of current T3 assays, best practices, and more [36:00];
Genetic and sex-based variability in thyroid hormone regulation and their limited clinical significance [43:45];
Hyperthyroidism: causes, symptoms, diagnosis, and treatment options [46:00];
Hypothyroidism: diagnosis and autoimmune causes of hypothyroidism [56:30];
More on hypothyroidism: diagnostic biomarkers, antibody patterns, and non-autoimmune presentations [1:05:00];
Thyroid hormone replacement therapy [1:15:15];
More on thyroid replacement strategies: exploring the evidence gaps, mortality signals, effects on lipids, and more [1:28:00];
Hypothyroidism basics: causes, antibody implication

Mindsip insights from this episode:

Demand mass spectrometry for reliable T3 testing

Common lab immunoassays for T3 and especially reverse T3 are not good, particularly at low levels, and require mass spectrometry for reliable results, which is not widely available clinically.

#diagnosis

#testing

Question the efficacy of compounded slow-release T3 formulations

There is no scientific publication showing that popular compounded "slow-release" T3 formulations actually exhibit a slow-release profile in the body.

#compounding

Reevaluate radioactive iodine treatment due to cancer risk

Radioactive iodine treatment for hyperthyroidism, once a standard therapy, is now known to be associated with an increased risk of developing other types of cancer.

#cancer

Reevaluate hypothyroidism treatment to reduce mortality risk

Retrospective data shows that patients treated with standard levothyroxine for hypothyroidism have a 2.5 times greater mortality rate compared to healthy controls.

#deficiency

#mortality

Recognize TSH range increases with age for accurate health assessment

After age 50, the upper limit of the normal TSH range increases by about one point every decade, meaning a TSH of 8 can be normal for an 80-year-old.

#aging

Understand brain's local T3 production for accurate health insights

Most of the active thyroid hormone (T3) in the brain is produced locally by the D2 enzyme and does not come from the blood, explaining why blood levels don't always reflect brain status.

#neurology

#thyroid

Implement combination therapy to lower mortality in hypothyroid patients

In a large retrospective study, hypothyroid patients on combination T4/T3 therapy had a 30% lower mortality rate than those on T4 monotherapy.

#mortality

#therapy

Limit iodine intake to prevent autoimmune thyroid disease

Excessive iodine intake, far above the recommended daily amount of 150 micrograms, is known to increase the incidence of autoimmune thyroid disease.

#autoimmunity

#deficiency

Question levothyroxine's efficacy due to lack of clinical trials

The FDA never required a single clinical trial to prove the efficacy of levothyroxine (Synthroid) for outcomes like mortality reduction before it became the standard of care.

#clinical-trial

Peter Attia

#387 - AMA #83: Peptides—evaluating the science, safety, and hype in a rapidly growing field

#386 - Aging clocks—what they measure, how they work, and their clinical and real-world relevance

#384 - Special episode — Obicetrapib: The CETP inhibitor with cardiovascular benefits and potential Alzheimer's prevention

Alzheimer's disease in women: how hormonal transitions impact the female brain, the role of HRT, genetics, and lifestyle on risk, and emerging diagnostics and therapies | Lisa Mosconi, Ph.D.

Women's health and performance: how training, nutrition, and hormones interact across life stages | Abbie Smith-Ryan, Ph.D.